BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bissell DM. Chronic liver injury, TGF-β, and cancer. Exp Mol Med 2001;33:179-90. [DOI: 10.1038/emm.2001.31] [Cited by in Crossref: 123] [Cited by in F6Publishing: 118] [Article Influence: 5.9] [Reference Citation Analysis]
Number Citing Articles
1 Giannelli G, Mazzocca A, Fransvea E, Lahn M, Antonaci S. Inhibiting TGF-β signaling in hepatocellular carcinoma. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2011;1815:214-23. [DOI: 10.1016/j.bbcan.2010.11.004] [Cited by in Crossref: 14] [Cited by in F6Publishing: 45] [Article Influence: 1.3] [Reference Citation Analysis]
2 Çolakoğlu N, Kükner A. Effects of high dose retinoic acid on adult rat liver: electron microscopic and immunohistochemical study. Nutrition Research 2003;23:509-17. [DOI: 10.1016/s0271-5317(02)00542-0] [Cited by in Crossref: 4] [Article Influence: 0.2] [Reference Citation Analysis]
3 Pham T, Marion M, Denizeau F, Jumarie C. Cadmium-induced apoptosis in rat hepatocytes does not necessarily involve caspase-dependent pathways. Toxicology in Vitro 2006;20:1331-42. [DOI: 10.1016/j.tiv.2006.05.005] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 1.9] [Reference Citation Analysis]
4 Kikuchi S, Griffin CT, Wang S, Bissell DM. Role of CD44 in Epithelial Wound Repair. Journal of Biological Chemistry 2005;280:15398-404. [DOI: 10.1074/jbc.m414048200] [Cited by in Crossref: 38] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
5 Singh H, Sidhu S, Chopra K, Khan MU. Hepatoprotective effect of trans-Chalcone on experimentally induced hepatic injury in rats: inhibition of hepatic inflammation and fibrosis. Can J Physiol Pharmacol 2016;94:879-87. [PMID: 27191034 DOI: 10.1139/cjpp-2016-0071] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
6 Kim KH, Kim HC, Hwang MY, Oh HK, Lee TS, Chang YC, Song HJ, Won NH, Park KK. The antifibrotic effect of TGF-beta1 siRNAs in murine model of liver cirrhosis. Biochem Biophys Res Commun. 2006;343:1072-1078. [PMID: 16579972 DOI: 10.1016/j.bbrc.2006.03.087] [Cited by in Crossref: 33] [Cited by in F6Publishing: 43] [Article Influence: 2.1] [Reference Citation Analysis]
7 Mohy A, Fouad A. Role of transforming growth factor-β1 in serum and - 509 C>T promoter gene polymorphism in development of liver cirrhosis in Egyptian patients. Meta Gene 2014;2:631-7. [PMID: 25606446 DOI: 10.1016/j.mgene.2014.08.002] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
8 LeClair RJ, Durmus T, Wang Q, Pyagay P, Terzic A, Lindner V. Cthrc1 is a novel inhibitor of transforming growth factor-beta signaling and neointimal lesion formation. Circ Res 2007;100:826-33. [PMID: 17322174 DOI: 10.1161/01.RES.0000260806.99307.72] [Cited by in Crossref: 70] [Cited by in F6Publishing: 43] [Article Influence: 4.7] [Reference Citation Analysis]
9 He YT, Liu DW, Ding LY, Li Q, Xiao YH. Therapeutic effects and molecular mechanisms of anti-fibrosis herbs and selenium on rats with hepatic fibrosis. World J Gastroenterol 2004; 10(5): 703-706 [PMID: 14991942 DOI: 10.3748/wjg.v10.i5.703] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 13] [Article Influence: 0.7] [Reference Citation Analysis]
10 Zhang YM, Chen XM, Wu D, Shi SZ, Yin Z, Ding R, Lü Y. Expression of tissue inhibitor of matrix metalloproteinases-1 during aging in rat liver. World J Gastroenterol 2005; 11(24): 3696-3700 [PMID: 15968723 DOI: 10.3748/wjg.v11.i24.3696] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.4] [Reference Citation Analysis]
11 Wilkes MC, Murphy SJ, Garamszegi N, Leof EB. Cell-type-specific activation of PAK2 by transforming growth factor beta independent of Smad2 and Smad3. Mol Cell Biol 2003;23:8878-89. [PMID: 14612425 DOI: 10.1128/MCB.23.23.8878-8889.2003] [Cited by in Crossref: 103] [Cited by in F6Publishing: 59] [Article Influence: 5.4] [Reference Citation Analysis]
12 O'Connor JW, Gomez EW. Biomechanics of TGFβ-induced epithelial-mesenchymal transition: implications for fibrosis and cancer. Clin Transl Med 2014;3:23. [PMID: 25097726 DOI: 10.1186/2001-1326-3-23] [Cited by in Crossref: 72] [Cited by in F6Publishing: 78] [Article Influence: 9.0] [Reference Citation Analysis]
13 Nagler A, Ohana M, Shibolet O, Shapira M, Alper R, Vlodavsky I, Pines M, Ilan Y. Suppression of hepatocellular carcinoma growth in mice by the alkaloid coccidiostat halofuginone. European Journal of Cancer 2004;40:1397-403. [DOI: 10.1016/j.ejca.2003.11.036] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 2.1] [Reference Citation Analysis]
14 Yang P, Li QJ, Feng Y, Zhang Y, Markowitz GJ, Ning S, Deng Y, Zhao J, Jiang S, Yuan Y, Wang HY, Cheng SQ, Xie D, Wang XF. TGF-β-miR-34a-CCL22 signaling-induced Treg cell recruitment promotes venous metastases of HBV-positive hepatocellular carcinoma. Cancer Cell 2012;22:291-303. [PMID: 22975373 DOI: 10.1016/j.ccr.2012.07.023] [Cited by in Crossref: 317] [Cited by in F6Publishing: 318] [Article Influence: 31.7] [Reference Citation Analysis]
15 Dituri F, Mazzocca A, Peidro FJ, Papappicco P, Fabregat I, De Santis F, Paradiso A, Sabba C, Giannelli G. Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II. PLoS One. 2013;8:e67109. [PMID: 23826206 DOI: 10.1371/journal.pone.0067109] [Cited by in Crossref: 60] [Cited by in F6Publishing: 62] [Article Influence: 6.7] [Reference Citation Analysis]
16 Zhu H, Bona C, Mcgaha TL. Polymorphisms of the TGF-β1 Promoter in Tight Skin (TSK) Mice. Autoimmunity 2009;37:51-5. [DOI: 10.1080/08916930310001633782] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
17 Uesugi T, Froh M, Gäbele E, Isayama F, Bradford BU, Ikai I, Yamaoka Y, Arteel GE. Contribution of Angiotensin II to Alcohol-Induced Pancreatic Fibrosis in Rats. J Pharmacol Exp Ther 2004;311:921-8. [DOI: 10.1124/jpet.104.071324] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
18 Ogata H, Chinen T, Yoshida T, Kinjyo I, Takaesu G, Shiraishi H, Iida M, Kobayashi T, Yoshimura A. Loss of SOCS3 in the liver promotes fibrosis by enhancing STAT3-mediated TGF-beta1 production. Oncogene. 2006;25:2520-2530. [PMID: 16474852 DOI: 10.1038/sj.onc.1209281] [Cited by in Crossref: 157] [Cited by in F6Publishing: 168] [Article Influence: 9.8] [Reference Citation Analysis]
19 Hung W, Yang G, Wang Y, Chiou Y, Tung Y, Yang M, Wang B, Ho C, Wang Y, Pan M. Protective effects of theasinensin A against carbon tetrachloride-induced liver injury in mice. Food Funct 2017;8:3276-87. [DOI: 10.1039/c7fo00700k] [Cited by in Crossref: 15] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
20 Nurgazieva D, Mickley A, Moganti K, Ming W, Ovsyi I, Popova A, Sachindra, Awad K, Wang N, Bieback K, Goerdt S, Kzhyshkowska J, Gratchev A. TGF-β1, but not bone morphogenetic proteins, activates Smad1/5 pathway in primary human macrophages and induces expression of proatherogenic genes. J Immunol 2015;194:709-18. [PMID: 25505291 DOI: 10.4049/jimmunol.1300272] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 2.8] [Reference Citation Analysis]
21 Liu YF, Zha BS, Zhang HL, Zhu XJ, Li YH, Zhu J, Guan XH, Feng ZQ, Zhang JP. Characteristic gene expression profiles in the progression from liver cirrhosis to carcinoma induced by diethylnitrosamine in a rat model. J Exp Clin Cancer Res 2009;28:107. [PMID: 19638242 DOI: 10.1186/1756-9966-28-107] [Cited by in Crossref: 28] [Cited by in F6Publishing: 27] [Article Influence: 2.2] [Reference Citation Analysis]
22 Daniels CE, Wilkes MC, Edens M, Kottom TJ, Murphy SJ, Limper AH, Leof EB. Imatinib mesylate inhibits the profibrogenic activity of TGF-beta and prevents bleomycin-mediated lung fibrosis. J Clin Invest 2004;114:1308-16. [PMID: 15520863 DOI: 10.1172/JCI19603] [Cited by in Crossref: 15] [Cited by in F6Publishing: 199] [Article Influence: 0.8] [Reference Citation Analysis]
23 Wang ME, Chen YC, Chen IS, Hsieh SC, Chen SS, Chiu CH. Curcumin protects against thioacetamide-induced hepatic fibrosis by attenuating the inflammatory response and inducing apoptosis of damaged hepatocytes. J Nutr Biochem. 2012;23:1352-1366. [PMID: 22221674 DOI: 10.1016/j.jnutbio.2011.08.004] [Cited by in Crossref: 61] [Cited by in F6Publishing: 64] [Article Influence: 6.1] [Reference Citation Analysis]
24 Yang C, Su H, Liao X, Han C, Yu T, Zhu G, Wang X, Winkler CA, O'Brien SJ, Peng T. Marker of proliferation Ki-67 expression is associated with transforming growth factor beta 1 and can predict the prognosis of patients with hepatic B virus-related hepatocellular carcinoma. Cancer Manag Res 2018;10:679-96. [PMID: 29692627 DOI: 10.2147/CMAR.S162595] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
25 Migita K, Miyazoe S, Maeda Y, Daikoku M, Abiru S, Ueki T, Yano K, Nagaoka S, Matsumoto T, Nakao K. Cytokine gene polymorphisms in Japanese patients with hepatitis B virus infection--association between TGF-beta1 polymorphisms and hepatocellular carcinoma. J Hepatol. 2005;42:505-510. [PMID: 15763337 DOI: 10.1016/j.jhep.2004.11.026] [Cited by in Crossref: 106] [Cited by in F6Publishing: 114] [Article Influence: 5.9] [Reference Citation Analysis]
26 Kim CJ, Choi BJ, Song JH, Park YK, Cho YG, Nam SW, Yoo NJ, Lee JY, Park WS. Overexpression of serine-threonine receptor kinase-associated protein in colorectal cancers. Pathol Int. 2007;57:178-182. [PMID: 17316412 DOI: 10.1111/j.1440-1827.2007.02078.x] [Cited by in Crossref: 17] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
27 Furtado KS, Polletini J, Dias MC, Rodrigues MA, Barbisan LF. Prevention of rat liver fibrosis and carcinogenesis by coffee and caffeine. Food Chem Toxicol 2014;64:20-6. [PMID: 24275088 DOI: 10.1016/j.fct.2013.11.011] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
28 Yalak G, Vogel V. Ectokinases as novel cancer markers and drug targets in cancer therapy. Cancer Med 2015;4:404-14. [PMID: 25504773 DOI: 10.1002/cam4.368] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
29 Melton AC, Soon RK Jr, Park JG, Martinez L, Dehart GW, Yee HF Jr. Focal adhesion disassembly is an essential early event in hepatic stellate cell chemotaxis. Am J Physiol Gastrointest Liver Physiol. 2007;293:G1272-G1280. [PMID: 17947456 DOI: 10.1152/ajpgi.00134.2007] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
30 Ling H, Roux E, Hempel D, Tao J, Smith M, Lonning S, Zuk A, Arbeeny C, Ledbetter S. Transforming growth factor β neutralization ameliorates pre-existing hepatic fibrosis and reduces cholangiocarcinoma in thioacetamide-treated rats. PLoS One 2013;8:e54499. [PMID: 23349909 DOI: 10.1371/journal.pone.0054499] [Cited by in Crossref: 49] [Cited by in F6Publishing: 51] [Article Influence: 5.4] [Reference Citation Analysis]
31 Chopra S, Kumar N, Rangarajan A, Kondaiah P. Context dependent non canonical WNT signaling mediates activation of fibroblasts by transforming growth factor-β. Exp Cell Res 2015;334:246-59. [PMID: 25773780 DOI: 10.1016/j.yexcr.2015.03.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
32 Watanabe K, Mitsunaga S, Kojima M, Suzuki H, Irisawa A, Takahashi H, Sasaki M, Hashimoto Y, Imaoka H, Ohno I, Ikeda M, Akimoto T, Ochiai A. The "histological replacement growth pattern" represents aggressive invasive behavior in liver metastasis from pancreatic cancer. Cancer Med 2020;9:3130-41. [PMID: 32135041 DOI: 10.1002/cam4.2954] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
33 Devipriya N, Sudheer AR, Srinivasan M, Menon VP. Effect of Ellagic Acid, a Plant Polyphenol, on Fibrotic Markers (MMPs and TIMPs) during Alcohol-Induced Hepatotoxicity. Toxicology Mechanisms and Methods 2008;17:349-56. [DOI: 10.1080/15376510601077003] [Cited by in Crossref: 25] [Cited by in F6Publishing: 24] [Article Influence: 1.8] [Reference Citation Analysis]
34 Steenvoorden MM, Tolboom TC, van der Pluijm G, Löwik C, Visser CP, DeGroot J, Gittenberger-DeGroot AC, DeRuiter MC, Wisse BJ, Huizinga TW, Toes RE. Transition of healthy to diseased synovial tissue in rheumatoid arthritis is associated with gain of mesenchymal/fibrotic characteristics. Arthritis Res Ther 2006;8:R165. [PMID: 17076892 DOI: 10.1186/ar2073] [Cited by in Crossref: 51] [Cited by in F6Publishing: 54] [Article Influence: 3.4] [Reference Citation Analysis]
35 Dituri F, Serio G, Filannino D, Mascolo A, Sacco R, Villa E, Giannelli G. Circulating TGF-β1-related biomarkers in patients with hepatocellular carcinoma and their association with HCC staging scores. Cancer Lett. 2014;353:264-271. [PMID: 25088578 DOI: 10.1016/j.canlet.2014.07.029] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 2.3] [Reference Citation Analysis]
36 Hanpanich P, Pinlaor S, Charoensuk L, Yongvanit P, Thomas C, Kothan S, Mairiang E. MRI and (1)H MRS evaluation for the serial bile duct changes in hamsters after infection with Opisthorchis viverrini. Magn Reson Imaging 2013;31:1418-25. [PMID: 23891436 DOI: 10.1016/j.mri.2013.05.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
37 Wei X, Tang C, Lu X, Liu R, Zhou M, He D, Zheng D, Sun C, Wu Z. MiR-101 targets DUSP1 to regulate the TGF-β secretion in sorafenib inhibits macrophage-induced growth of hepatocarcinoma. Oncotarget 2015;6:18389-405. [PMID: 26158762 DOI: 10.18632/oncotarget.4089] [Cited by in Crossref: 36] [Cited by in F6Publishing: 37] [Article Influence: 6.0] [Reference Citation Analysis]
38 N/A. N/A. Shijie Huaren Xiaohua Zazhi 2003; 11(10): 1601-1605 [DOI: 10.11569/wcjd.v11.i10.1601] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
39 Ha MH, Rao HY, Liu F, Pan XB, Feng B, Chen HS, Wei L. Hepatitis B virus induces expression of connective tissue growth factor and transforming growth factor-β1 in hepatic stellate cells. Shijie Huaren Xiaohua Zazhi 2008; 16(9): 924-928 [DOI: 10.11569/wcjd.v16.i9.924] [Reference Citation Analysis]
40 Wu K, Ding J, Chen C, Sun W, Ning BF, Wen W, Huang L, Han T, Yang W, Wang C, Li Z, Wu MC, Feng GS, Xie WF, Wang HY. Hepatic transforming growth factor beta gives rise to tumor-initiating cells and promotes liver cancer development. Hepatology. 2012;56:2255-2267. [PMID: 22898879 DOI: 10.1002/hep.26007] [Cited by in Crossref: 149] [Cited by in F6Publishing: 138] [Article Influence: 16.6] [Reference Citation Analysis]
41 Wu XZ, Chen D, Xie GR. Extracellular matrix remodeling in hepatocellular carcinoma: effects of soil on seed? Med Hypotheses 2006;66:1115-20. [PMID: 16504415 DOI: 10.1016/j.mehy.2005.12.043] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
42 Ruehl M, Erben U, Kim K, Freise C, Dagdelen T, Eisele S, Trowitzsch-Kienast W, Zeitz M, Jia J, Stickel F. Extracts of Lindera obtusiloba induce antifibrotic effects in hepatic stellate cells via suppression of a TGF-beta-mediated profibrotic gene expression pattern. J Nutr Biochem. 2009;20:597-606. [PMID: 18824344 DOI: 10.1016/j.jnutbio.2008.06.003] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
43 Munshi MK, Uddin MN, Glaser SS. The role of the renin-angiotensin system in liver fibrosis. Exp Biol Med (Maywood). 2011;236:557-566. [PMID: 21508249 DOI: 10.1258/ebm.2011.010375] [Cited by in Crossref: 41] [Cited by in F6Publishing: 36] [Article Influence: 3.7] [Reference Citation Analysis]
44 Booth AJ, Hadley R, Cornett AM, Dreffs AA, Matthes SA, Tsui JL, Weiss K, Horowitz JC, Fiore VF, Barker TH, Moore BB, Martinez FJ, Niklason LE, White ES. Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation. Am J Respir Crit Care Med 2012;186:866-76. [PMID: 22936357 DOI: 10.1164/rccm.201204-0754OC] [Cited by in Crossref: 364] [Cited by in F6Publishing: 207] [Article Influence: 36.4] [Reference Citation Analysis]
45 Wu SK, Wang BJ, Yang Y, Feng XH, Zhao XP, Yang DL. Expression of PTEN, PPM1A and P-Smad2 in hepatocellular carcinomas and adjacent liver tissues. World J Gastroenterol 2007; 13(34): 4554-4559 [PMID: 17729405 DOI: 10.3748/wjg.v13.i34.4554] [Cited by in CrossRef: 32] [Cited by in F6Publishing: 27] [Article Influence: 2.1] [Reference Citation Analysis]
46 Murata M, Yoshida K, Yamaguchi T, Matsuzaki K. Linker phosphorylation of Smad3 promotes fibro-carcinogenesis in chronic viral hepatitis of hepatocellular carcinoma. World J Gastroenterol 2014; 20(41): 15018-15027 [PMID: 25386050 DOI: 10.3748/wjg.v20.i41.15018] [Cited by in CrossRef: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
47 Xu XB, Leng XS, He ZP, Liang ZQ. Smad4 antisense gene transfer into ito cells and suppressed extracellular matrix production. Shijie Huaren Xiaohua Zazhi 2003; 11(11): 1690-1693 [DOI: 10.11569/wcjd.v11.i11.1690] [Reference Citation Analysis]
48 Shin DM, Jeon JH, Kim CW, Cho SY, Lee HJ, Jang GY, Jeong EM, Lee DS, Kang JH, Melino G, Park SC, Kim IG. TGFbeta mediates activation of transglutaminase 2 in response to oxidative stress that leads to protein aggregation. FASEB J 2008;22:2498-507. [PMID: 18353867 DOI: 10.1096/fj.07-095455] [Cited by in Crossref: 51] [Cited by in F6Publishing: 50] [Article Influence: 3.6] [Reference Citation Analysis]
49 Murphy SJ, Shapira KE, Henis YI, Leof EB. A unique element in the cytoplasmic tail of the type II transforming growth factor-beta receptor controls basolateral delivery. Mol Biol Cell 2007;18:3788-99. [PMID: 17634290 DOI: 10.1091/mbc.e06-10-0930] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 1.3] [Reference Citation Analysis]
50 Eurich D, Bahra M, Boas-knoop S, Lock JF, Golembus J, Neuhaus R, Neuhaus P, Neumann UP. Transforming growth factor β1 polymorphisms and progression of graft fibrosis after liver transplantation for hepatitis C virus--induced liver disease. Liver Transpl 2011;17:279-88. [DOI: 10.1002/lt.22190] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
51 Sun H, Zhong X, Wang C, Wang S, Lin L, Zou R, Wu Y, Sun N, Sun G, Wen T, Chi Z, Zhao Y. SNF5 is Involved in Suppression of Hepatocellular Carcinoma Progression via TGF-Beta 1 Signaling: SNF5 Suppresses Hepatocellular Carcinoma Progression. Anat Rec 2016;299:869-77. [DOI: 10.1002/ar.23357] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
52 de Oliveira Fdos S, Kieling CO, dos Santos JL, de Leon Lima PP, Vieira S, Meurer L, da Silveira TR, Matte U. Serum and tissue transforming [corrected] growth factor β1 in children with biliary atresia. J Pediatr Surg 2010;45:1784-90. [PMID: 20850621 DOI: 10.1016/j.jpedsurg.2010.04.007] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
53 Niwa O, Barcellos-Hoff MH, Globus RK, Harrison JD, Hendry JH, Jacob P, Martin MT, Seed TM, Shay JW, Story MD, Suzuki K, Yamashita S; ICRP. ICRP Publication 131: Stem Cell Biology with Respect to Carcinogenesis Aspects of Radiological Protection. Ann ICRP 2015;44:7-357. [PMID: 26637346 DOI: 10.1177/0146645315595585] [Cited by in Crossref: 24] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
54 Avila MA, Berasain C, Sangro B, Prieto J. New therapies for hepatocellular carcinoma. Oncogene. 2006;25:3866-3884. [PMID: 16799628 DOI: 10.1038/sj.onc.1209550] [Cited by in Crossref: 269] [Cited by in F6Publishing: 260] [Article Influence: 16.8] [Reference Citation Analysis]
55 Radisky DC, Kenny PA, Bissell MJ. Fibrosis and cancer: do myofibroblasts come also from epithelial cells via EMT? J Cell Biochem. 2007;101:830-839. [PMID: 17211838 DOI: 10.1002/jcb.21186] [Cited by in Crossref: 239] [Cited by in F6Publishing: 238] [Article Influence: 15.9] [Reference Citation Analysis]
56 Hackl NJ, Bersch C, Feick P, Antoni C, Franke A, Singer MV, Nakchbandi IA. Circulating fibronectin isoforms predict the degree of fibrosis in chronic hepatitis C. Scand J Gastroenterol. 2010;45:349-356. [PMID: 20017652 DOI: 10.3109/00365520903490606] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.3] [Reference Citation Analysis]
57 Zhang D, Wang NY, Yang CB, Fang GX, Liu W, Wen J, Luo C. The clinical value of serum connective tissue growth factor in the assessment of liver fibrosis. Dig Dis Sci. 2010;55:767-774. [PMID: 19294506 DOI: 10.1007/s10620-009-0781-9] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 1.2] [Reference Citation Analysis]
58 Daniels CE, Wilkes MC, Edens M, Kottom TJ, Murphy SJ, Limper AH, Leof EB. Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis. J Clin Invest 2004;114:1308-16. [DOI: 10.1172/jci200419603] [Cited by in Crossref: 421] [Article Influence: 23.4] [Reference Citation Analysis]
59 Kikuchi H, Katsuramaki T, Kukita K, Taketani S, Meguro M, Nagayama M, Isobe M, Mizuguchi T, Hirata K. New strategy for the antifibrotic therapy with oral administration of FR260330 (a selective inducible nitric oxide synthase inhibitor) in rat experimental liver cirrhosis. Wound Repair Regen. 2007;15:881-888. [PMID: 18028137 DOI: 10.1111/j.1524-475X.2007.00308.x] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
60 Iordanskaia T, Nawshad A. Mechanisms of transforming growth factor β induced cell cycle arrest in palate development. J Cell Physiol 2011;226:1415-24. [PMID: 20945347 DOI: 10.1002/jcp.22477] [Cited by in Crossref: 33] [Cited by in F6Publishing: 34] [Article Influence: 3.0] [Reference Citation Analysis]
61 Zindy PJ, L'Helgoualc'h A, Bonnier D, Le Béchec A, Bourd-Boitin K, Zhang CX, Orlando Musso O, Glaise D, Bérangère Troadec M, Loréal O. Upregulation of the tumor suppressor gene menin in hepatocellular carcinomas and its significance in fibrogenesis. Hepatology. 2006;44:1296-1307. [PMID: 17058241 DOI: 10.1002/hep.21367] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 1.3] [Reference Citation Analysis]
62 Li HX, Zheng JH, Fan HX, Li HP, Gao ZX, Chen D. Expression of αvβ6 integrin and collagen fibre in oral squamous cell carcinoma: association with clinical outcomes and prognostic implications. J Oral Pathol Med 2013;42:547-56. [PMID: 23331428 DOI: 10.1111/jop.12044] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 2.3] [Reference Citation Analysis]
63 Angadi PV, Kale AD, Hallikerimath S. Evaluation of myofibroblasts in oral submucous fibrosis: correlation with disease severity. J Oral Pathol Med. 2011;40:208-213. [PMID: 21198872 DOI: 10.1111/j.1600-0714.2010.00995.x] [Cited by in Crossref: 40] [Cited by in F6Publishing: 44] [Article Influence: 3.3] [Reference Citation Analysis]
64 You H, Ding W, Rountree CB. Epigenetic regulation of cancer stem cell marker CD133 by transforming growth factor-beta. Hepatology 2010;51:1635-44. [PMID: 20196115 DOI: 10.1002/hep.23544] [Cited by in Crossref: 147] [Cited by in F6Publishing: 135] [Article Influence: 12.3] [Reference Citation Analysis]
65 Wu XL, Zeng WZ, Wang PL, Lei CT, Jiang MD, Chen XB, Zhang Y, Xu H, Wang Z. Effect of compound rhodiola sachalinensis A Bor on CCl4-induced liver fibrosis in rats and its probable molecular mechanisms. World J Gastroenterol 2003; 9(7): 1559-1562 [PMID: 12854163 DOI: 10.3748/wjg.v9.i7.1559] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
66 Shi YS, Li XX, Li HT, Zhang Y. Pelargonidin ameliorates CCl4-induced liver fibrosis by suppressing the ROS-NLRP3-IL-1β axis via activating the Nrf2 pathway. Food Funct 2020;11:5156-65. [PMID: 32432601 DOI: 10.1039/d0fo00660b] [Cited by in Crossref: 8] [Cited by in F6Publishing: 2] [Article Influence: 8.0] [Reference Citation Analysis]
67 Kuroda N, Mizobuchi M, Shimamura Y, Daibata M, Miyoshi I, Ohara M, Hirouchi T, Mizuno K, Lee GH. Bridging necrosis and reticulin bridging fibrosis induced by intrahepatic involvement of acute biphenotypic leukemia. APMIS 2006;114:908-11. [PMID: 17207092 DOI: 10.1111/j.1600-0463.2006.apm_540.x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
68 Mazzocca A, Fransvea E, Dituri F, Lupo L, Antonaci S, Giannelli G. Down-regulation of connective tissue growth factor by inhibition of transforming growth factor beta blocks the tumor-stroma cross-talk and tumor progression in hepatocellular carcinoma. Hepatology. 2010;51:523-534. [PMID: 19821534 DOI: 10.1002/hep.23285] [Cited by in Crossref: 113] [Cited by in F6Publishing: 119] [Article Influence: 9.4] [Reference Citation Analysis]
69 Rahimi RA, Leof EB. TGF-beta signaling: a tale of two responses. J Cell Biochem. 2007;102:593-608. [PMID: 17729308 DOI: 10.1002/jcb.21501] [Cited by in Crossref: 279] [Cited by in F6Publishing: 263] [Article Influence: 19.9] [Reference Citation Analysis]
70 Furtado KS, Prado MG, Aguiar E Silva MA, Dias MC, Rivelli DP, Rodrigues MA, Barbisan LF. Coffee and caffeine protect against liver injury induced by thioacetamide in male Wistar rats. Basic Clin Pharmacol Toxicol 2012;111:339-47. [PMID: 22646289 DOI: 10.1111/j.1742-7843.2012.00903.x] [Cited by in Crossref: 51] [Cited by in F6Publishing: 47] [Article Influence: 5.1] [Reference Citation Analysis]
71 Lam HB, Yeh CH, Cheng KC, Hsu CT, Cheng JT. Effect of cholinergic denervation on hepatic fibrosis induced by carbon tetrachloride in rats. Neurosci Lett 2008;438:90-5. [PMID: 18472332 DOI: 10.1016/j.neulet.2008.04.048] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
72 Wang B, Dolinski BM, Kikuchi N, Leone DR, Peters MG, Weinreb PH, Violette SM, Bissell DM. Role of alphavbeta6 integrin in acute biliary fibrosis. Hepatology. 2007;46:1404-1412. [PMID: 17924447 DOI: 10.1002/hep.21849] [Cited by in Crossref: 122] [Cited by in F6Publishing: 114] [Article Influence: 8.1] [Reference Citation Analysis]
73 He X, Guo X, Zhang H, Kong X, Yang F, Zheng C. Mechanism of action and efficacy of LY2109761, a TGF-β receptor inhibitor, targeting tumor microenvironment in liver cancer after TACE. Oncotarget 2018;9:1130-42. [PMID: 29416682 DOI: 10.18632/oncotarget.23193] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
74 Mölleken C, Ahrens M, Schlosser A, Dietz J, Eisenacher M, Meyer HE, Schmiegel W, Holmskov U, Sarrazin C, Sorensen GL, Sitek B, Bracht T. Direct-acting antivirals-based therapy decreases hepatic fibrosis serum biomarker microfibrillar-associated protein 4 in hepatitis C patients. Clin Mol Hepatol 2019;25:42-51. [PMID: 30449076 DOI: 10.3350/cmh.2018.0029] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
75 Wallach CJ, Kim JS, Sobajima S, Lattermann C, Oxner WM, McFadden K, Robbins PD, Gilbertson LG, Kang JD. Safety assessment of intradiscal gene transfer: a pilot study. Spine J. 2006;6:107-112. [PMID: 16517379 DOI: 10.1016/j.spinee.2005.05.002] [Cited by in Crossref: 45] [Cited by in F6Publishing: 39] [Article Influence: 2.8] [Reference Citation Analysis]
76 Gotzmann J, Mikula M, Eger A, Schulte-Hermann R, Foisner R, Beug H, Mikulits W. Molecular aspects of epithelial cell plasticity: implications for local tumor invasion and metastasis. Mutat Res. 2004;566:9-20. [PMID: 14706509 DOI: 10.1016/S1383-5742(03)00033-4] [Cited by in Crossref: 220] [Cited by in F6Publishing: 115] [Article Influence: 12.2] [Reference Citation Analysis]
77 Nielsen K, Rolff HC, Eefsen RL, Vainer B. The morphological growth patterns of colorectal liver metastases are prognostic for overall survival. Mod Pathol 2014;27:1641-8. [PMID: 24851832 DOI: 10.1038/modpathol.2014.4] [Cited by in Crossref: 53] [Cited by in F6Publishing: 48] [Article Influence: 6.6] [Reference Citation Analysis]
78 Hashimoto K, Mori N, Tamesa T, Okada T, Kawauchi S, Oga A, Furuya T, Tangoku A, Oka M, Sasaki K. Analysis of DNA copy number aberrations in hepatitis C virus-associated hepatocellular carcinomas by conventional CGH and array CGH. Mod Pathol 2004;17:617-22. [DOI: 10.1038/modpathol.3800107] [Cited by in Crossref: 75] [Cited by in F6Publishing: 71] [Article Influence: 4.2] [Reference Citation Analysis]
79 Lee SL, Hsu WH, Tu CM, Wang WH, Yang CY, Lee HK, Chin TY. The Effects of Freshwater Clam (Corbicula fluminea) Extract on Activated Hepatic Stellate Cells. Evid Based Complement Alternat Med 2021;2021:6065168. [PMID: 34804181 DOI: 10.1155/2021/6065168] [Reference Citation Analysis]
80 Lagoa CE, Vodovotz Y, Stolz DB, Lhuillier F, Mccloskey C, Gallo D, Yang R, Ustinova E, Fink MP, Billiar TR, Mars WM. The role of hepatic type 1 plasminogen activator inhibitor (PAI-1) during murine hemorrhagic shock. Hepatology 2005;42:390-9. [DOI: 10.1002/hep.20797] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 1.5] [Reference Citation Analysis]
81 Guo P, Sun X, Feng X, Zhang C. Transforming growth factor-β1 gene polymorphisms with liver cirrhosis risk: A meta-analysis. Infect Genet Evol 2018;58:164-70. [PMID: 29275189 DOI: 10.1016/j.meegid.2017.12.019] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
82 Wu XZ, Yu XH. Bone marrow cells: the source of hepatocellular carcinoma? Med Hypotheses. 2007;69:36-42. [PMID: 17300877 DOI: 10.1016/j.mehy.2006.10.064] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
83 Gilkes DM, Semenza GL, Wirtz D. Hypoxia and the extracellular matrix: drivers of tumour metastasis. Nat Rev Cancer. 2014;14:430-439. [PMID: 24827502 DOI: 10.1038/nrc3726] [Cited by in Crossref: 644] [Cited by in F6Publishing: 612] [Article Influence: 80.5] [Reference Citation Analysis]
84 Kangjian W, Nianhua D, Shiwei X, Yichun Y, Weihua D. Preparation and Characterization of Collagen–Chitosan–Chondroitin Sulfate Composite Membranes. J Membrane Biol 2012;245:707-16. [DOI: 10.1007/s00232-012-9442-6] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 1.8] [Reference Citation Analysis]
85 Haque A, Gheibi P, Gao Y, Foster E, Son KJ, You J, Stybayeva G, Patel D, Revzin A. Cell biology is different in small volumes: endogenous signals shape phenotype of primary hepatocytes cultured in microfluidic channels. Sci Rep 2016;6:33980. [PMID: 27681582 DOI: 10.1038/srep33980] [Cited by in Crossref: 24] [Cited by in F6Publishing: 21] [Article Influence: 4.0] [Reference Citation Analysis]
86 LeClair R, Lindner V. The role of collagen triple helix repeat containing 1 in injured arteries, collagen expression, and transforming growth factor beta signaling. Trends Cardiovasc Med 2007;17:202-5. [PMID: 17662915 DOI: 10.1016/j.tcm.2007.05.004] [Cited by in Crossref: 40] [Cited by in F6Publishing: 37] [Article Influence: 2.7] [Reference Citation Analysis]
87 Lee Y, Friedman SL. Fibrosis in the Liver. Development, Differentiation and Disease of the Para-Alimentary Tract. Elsevier; 2010. pp. 151-200. [DOI: 10.1016/b978-0-12-385233-5.00006-4] [Cited by in Crossref: 22] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
88 Takagi H, Manabe H, Sekino S, Kato T, Matsuno Y, Umemoto T. Coexistent aortic dissection and hepatocellular carcinoma with elevated plasma transforming growth factor beta level: possible roles of fibrillin 1 and transforming growth factor beta. J Thorac Cardiovasc Surg 2005;129:462-3. [PMID: 15678071 DOI: 10.1016/j.jtcvs.2004.06.033] [Reference Citation Analysis]
89 Lee SH, Do SI, Kim HS. Hyperoxia accelerates progression of hepatic fibrosis by up-regulation of transforming growth factor-β expression. World J Gastroenterol 2014; 20(11): 3011-3017 [PMID: 24659892 DOI: 10.3748/wjg.v20.i11.3011] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
90 Daniels JT, Schultz GS, Blalock TD, Garrett Q, Grotendorst GR, Dean NM, Khaw PT. Mediation of transforming growth factor-beta(1)-stimulated matrix contraction by fibroblasts: a role for connective tissue growth factor in contractile scarring. Am J Pathol 2003;163:2043-52. [PMID: 14578203 DOI: 10.1016/s0002-9440(10)63562-6] [Cited by in Crossref: 72] [Cited by in F6Publishing: 37] [Article Influence: 3.8] [Reference Citation Analysis]
91 Davila S, Froeling FE, Tan A, Bonnard C, Boland GJ, Snippe H, Hibberd ML, Seielstad M. New genetic associations detected in a host response study to hepatitis B vaccine. Genes Immun. 2010;11:232-238. [PMID: 20237496 DOI: 10.1038/gene.2010.1] [Cited by in Crossref: 58] [Cited by in F6Publishing: 53] [Article Influence: 4.8] [Reference Citation Analysis]
92 Hinz B, Darby IA, Gabbiani G, Desmoulière A. The Role of the Myofibroblast in Fibrosis and Cancer Progression. In: Mueller MM, Fusenig NE, editors. Tumor-Associated Fibroblasts and their Matrix. Dordrecht: Springer Netherlands; 2011. pp. 37-74. [DOI: 10.1007/978-94-007-0659-0_3] [Cited by in Crossref: 6] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
93 Radwan MI, Pasha HF, Mohamed RH, Hussien HI, El-Khshab MN. Influence of transforming growth factor-β1 and tumor necrosis factor-α genes polymorphisms on the development of cirrhosis and hepatocellular carcinoma in chronic hepatitis C patients. Cytokine. 2012;60:271-276. [PMID: 22682513 DOI: 10.1016/j.cyto.2012.05.010] [Cited by in Crossref: 39] [Cited by in F6Publishing: 35] [Article Influence: 3.9] [Reference Citation Analysis]
94 Gruel J, Leborgne M, LeMeur N, Théret N. In silico investigation of ADAM12 effect on TGF-beta receptors trafficking. BMC Res Notes 2009;2:193. [PMID: 19778441 DOI: 10.1186/1756-0500-2-193] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
95 Maarten Egeler R, van Halteren AGS, Hogendoorn PCW, Laman JD, Leenen PJM. Langerhans cell histiocytosis: fascinating dynamics of the dendritic cell-macrophage lineage. Immunological Reviews 2010;234:213-32. [DOI: 10.1111/j.0105-2896.2009.00883.x] [Cited by in Crossref: 79] [Cited by in F6Publishing: 65] [Article Influence: 6.6] [Reference Citation Analysis]
96 Xiong LJ, Zhu JF, Luo DD, Zen LL, Cai SQ. Effects of pentoxifylline on the hepatic content of TGF-β1 and collagen in Schistosomiasis japonica mice with liver fibrosis. World J Gastroenterol 2003; 9(1): 152-154 [PMID: 12508372 DOI: 10.3748/wjg.v9.i1.152] [Cited by in CrossRef: 20] [Cited by in F6Publishing: 19] [Article Influence: 1.1] [Reference Citation Analysis]
97 Saber S, Mahmoud AAA, Goda R, Helal NS, El-Ahwany E, Abdelghany RH. Perindopril, fosinopril and losartan inhibited the progression of diethylnitrosamine-induced hepatocellular carcinoma in mice via the inactivation of nuclear transcription factor kappa-B. Toxicol Lett. 2018;295:32-40. [PMID: 29859236 DOI: 10.1016/j.toxlet.2018.05.036] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 5.0] [Reference Citation Analysis]
98 Falleti E, Fabris C, Toniutto P, Fontanini E, Cussigh A, Bitetto D, Fornasiere E, Avellini C, Minisini R, Pirisi M. TGF-beta1 genotypes in cirrhosis: relationship with the occurrence of liver cancer. Cytokine. 2008;44:256-261. [PMID: 18809335 DOI: 10.1016/j.cyto.2008.08.008] [Cited by in Crossref: 26] [Cited by in F6Publishing: 23] [Article Influence: 1.9] [Reference Citation Analysis]
99 Rupert S, Selvaraj S, Malayaperumal S, Ramanathan R, Anbalagan C, Satyanesan J, Vennila R, Rajagopal S. Comparison of Extracellular Matrix (ECM) of Normal and D-Galactosamine-Induced Mice Model of Liver Injury Before and After Liver Decellularization. Regen Eng Transl Med 2021;7:405-15. [DOI: 10.1007/s40883-020-00153-3] [Reference Citation Analysis]
100 Ghani MU, Haque A, Iqbal MS, Ashfaq UA, Mausood MS, Qasim M, Jahan S, Shamsi FB, Yousaf M. TGF-β1 rs1800469 gene polymorphism in the development of cirrhosis & hepatocellular carcinoma in Pakistani HCV patients. Future Virology 2019;14:663-70. [DOI: 10.2217/fvl-2019-0047] [Reference Citation Analysis]
101 Murphy SJ, Doré JJ, Edens M, Coffey RJ, Barnard JA, Mitchell H, Wilkes M, Leof EB. Differential trafficking of transforming growth factor-beta receptors and ligand in polarized epithelial cells. Mol Biol Cell 2004;15:2853-62. [PMID: 15075369 DOI: 10.1091/mbc.e04-02-0097] [Cited by in Crossref: 39] [Cited by in F6Publishing: 31] [Article Influence: 2.2] [Reference Citation Analysis]
102 Migita K, Maeda Y, Abiru S, Nakamura M, Komori A, Yokoyama T, Takii Y, Mori T, Yatsuhashi H, Eguchi K, Ishibashi H. Immunosuppressant FK506 inhibits matrix metalloproteinase-9 induction in TNF-alpha-stimulated human hepatic stellate cells. Life Sci 2006;78:2510-5. [PMID: 16303143 DOI: 10.1016/j.lfs.2005.10.003] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.1] [Reference Citation Analysis]
103 Rathod SB, Tripathy AS. TGF-β1 gene - 509C > T promoter polymorphism modulates TGF-β1 levels in hepatitis E patients. Meta Gene 2015;6:53-8. [PMID: 26504745 DOI: 10.1016/j.mgene.2015.08.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
104 Mehner C, Radisky DC. Triggering the landslide: The tumor-promotional effects of myofibroblasts. Exp Cell Res 2013;319:1657-62. [PMID: 23528452 DOI: 10.1016/j.yexcr.2013.03.015] [Cited by in Crossref: 22] [Cited by in F6Publishing: 24] [Article Influence: 2.4] [Reference Citation Analysis]
105 Cheng K, Mahato RI. Gene modulation for treating liver fibrosis. Crit Rev Ther Drug Carrier Syst. 2007;24:93-146. [PMID: 17725523 DOI: 10.1615/critrevtherdrugcarriersyst.v24.i2.10] [Cited by in Crossref: 32] [Cited by in F6Publishing: 23] [Article Influence: 2.1] [Reference Citation Analysis]
106 Petrova V, Annicchiarico-Petruzzelli M, Melino G, Amelio I. The hypoxic tumour microenvironment. Oncogenesis. 2018;7:10. [PMID: 29362402 DOI: 10.1038/s41389-017-0011-9] [Cited by in Crossref: 317] [Cited by in F6Publishing: 303] [Article Influence: 79.3] [Reference Citation Analysis]
107 Zhao L, Gandhi CR, Gao ZH. Involvement of cytosolic phospholipase A2 alpha signalling pathway in spontaneous and transforming growth factor-beta-induced activation of rat hepatic stellate cells. Liver Int. 2011;31:1565-1573. [PMID: 22093332 DOI: 10.1111/j.1478-3231.2011.02632.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
108 Liu YK, Shen W. Inhibitive effect of cordyceps sinensis on experimental hepatic fibrosis and its possible mechanism. World J Gastroenterol 2003; 9(3): 529-533 [PMID: 12632512 DOI: 10.3748/wjg.v9.i3.529] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 26] [Article Influence: 1.4] [Reference Citation Analysis]
109 Bataller R, Sancho-Bru P, Ginès P, Brenner DA. Liver fibrogenesis: a new role for the renin-angiotensin system. Antioxid Redox Signal. 2005;7:1346-1355. [PMID: 16115040 DOI: 10.1089/ars.2005.7.1346] [Cited by in Crossref: 111] [Cited by in F6Publishing: 110] [Article Influence: 6.9] [Reference Citation Analysis]
110 Ding YF, Wu ZH, Wei YJ, Shu L, Peng YR. Hepatic inflammation-fibrosis-cancer axis in the rat hepatocellular carcinoma induced by diethylnitrosamine. J Cancer Res Clin Oncol 2017;143:821-34. [PMID: 28238064 DOI: 10.1007/s00432-017-2364-z] [Cited by in Crossref: 34] [Cited by in F6Publishing: 35] [Article Influence: 6.8] [Reference Citation Analysis]
111 Fischer AN, Fuchs E, Mikula M, Huber H, Beug H, Mikulits W. PDGF essentially links TGF-beta signaling to nuclear beta-catenin accumulation in hepatocellular carcinoma progression. Oncogene. 2007;26:3395-3405. [PMID: 17130832 DOI: 10.1038/sj.onc.1210121] [Cited by in Crossref: 101] [Cited by in F6Publishing: 94] [Article Influence: 6.3] [Reference Citation Analysis]
112 Lu N, Carracedo S, Ranta J, Heuchel R, Soininen R, Gullberg D. The human α11 integrin promoter drives fibroblast-restricted expression in vivo and is regulated by TGF-β1 in a Smad- and Sp1-dependent manner. Matrix Biology 2010;29:166-76. [DOI: 10.1016/j.matbio.2009.11.003] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 2.5] [Reference Citation Analysis]
113 Guo SG, Zhang W, Jiang T, Dai M, Zhang LF, Meng YC, Zhao LY, Niu JZ. Influence of serum collected from rat perfused with compound Biejiaruangan drug on hepatic stellate cells. World J Gastroenterol 2004; 10(10): 1487-1494 [PMID: 15133859 DOI: 10.3748/wjg.v10.i10.1487] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
114 Yin X, Murphy SJ, Wilkes MC, Ji Y, Leof EB. Retromer maintains basolateral distribution of the type II TGF-β receptor via the recycling endosome. Mol Biol Cell 2013;24:2285-98. [PMID: 23720763 DOI: 10.1091/mbc.E13-02-0093] [Cited by in Crossref: 25] [Cited by in F6Publishing: 19] [Article Influence: 2.8] [Reference Citation Analysis]
115 Micke P, Ostman A. Exploring the tumour environment: cancer-associated fibroblasts as targets in cancer therapy. Expert Opin Ther Targets 2005;9:1217-33. [PMID: 16300472 DOI: 10.1517/14728222.9.6.1217] [Cited by in Crossref: 107] [Cited by in F6Publishing: 105] [Article Influence: 6.7] [Reference Citation Analysis]
116 Sidgwick GP, Bayat A. Extracellular matrix molecules implicated in hypertrophic and keloid scarring. J Eur Acad Dermatol Venereol. 2012;26:141-152. [PMID: 21838832 DOI: 10.1111/j.1468-3083.2011.04200.x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 102] [Article Influence: 9.8] [Reference Citation Analysis]
117 Schulze-Krebs A, Preimel D, Popov Y, Bartenschlager R, Lohmann V, Pinzani M, Schuppan D. Hepatitis C virus-replicating hepatocytes induce fibrogenic activation of hepatic stellate cells. Gastroenterology. 2005;129:246-258. [PMID: 16012951 DOI: 10.1053/j.gastro.2005.03.089] [Cited by in Crossref: 107] [Cited by in F6Publishing: 96] [Article Influence: 6.3] [Reference Citation Analysis]
118 Bañares R, Núñez O, Escudero M, Fernández C, Vaquero J, Beceiro I, Echenagusía A, Clemente G, Santos L. Patients with cirrhosis and bare-stent TIPS may have increased risk of hepatocellular carcinoma. Hepatology 2005;41:566-71. [PMID: 15726654 DOI: 10.1002/hep.20576] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 1.4] [Reference Citation Analysis]
119 Hammad S, Cavalcanti E, Werle J, Caruso ML, Dropmann A, Ignazzi A, Ebert MP, Dooley S, Giannelli G. Galunisertib modifies the liver fibrotic composition in the Abcb4Ko mouse model. Arch Toxicol 2018;92:2297-309. [PMID: 29808285 DOI: 10.1007/s00204-018-2231-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 3.8] [Reference Citation Analysis]
120 Rafi SK, Goering JP, Olm-Shipman AJ, Hipp LA, Ernst NJ, Wilson NR, Hall EG, Gunewardena S, Saadi I. Anti-epileptic drug topiramate upregulates TGFβ1 and SOX9 expression in primary embryonic palatal mesenchyme cells: Implications for teratogenicity. PLoS One 2021;16:e0246989. [PMID: 33577554 DOI: 10.1371/journal.pone.0246989] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
121 Chen WT, Ha D, Kanel G, Lee AS. Targeted deletion of ER chaperone GRP94 in the liver results in injury, repopulation of GRP94-positive hepatocytes, and spontaneous hepatocellular carcinoma development in aged mice. Neoplasia. 2014;16:617-626. [PMID: 25220589 DOI: 10.1016/j.neo.2014.07.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 15] [Article Influence: 2.0] [Reference Citation Analysis]
122 Tessitore L, Bollito E. Early induction of TGF-beta1 through a fasting-re-feeding regimen promotes liver carcinogenesis by a sub-initiating dose of diethylnitrosamine. Cell Prolif 2006;39:105-16. [PMID: 16542346 DOI: 10.1111/j.1365-2184.2006.00371.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
123 Le Y, Chen L, Zhang Y, Bu P, Dai G, Cheng X. Epalrestat Stimulated Oxidative Stress, Inflammation, and Fibrogenesis in Mouse Liver. Toxicol Sci 2018;163:397-408. [PMID: 28204799 DOI: 10.1093/toxsci/kfx038] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
124 Burnier JV, Wang N, Michel RP, Hassanain M, Li S, Lu Y, Metrakos P, Antecka E, Burnier MN, Ponton A, Gallinger S, Brodt P. Type IV collagen-initiated signals provide survival and growth cues required for liver metastasis. Oncogene 2011;30:3766-83. [PMID: 21478904 DOI: 10.1038/onc.2011.89] [Cited by in Crossref: 64] [Cited by in F6Publishing: 57] [Article Influence: 5.8] [Reference Citation Analysis]